Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01681 CONSUN PHARMA
RTNominal up5.580 +0.180 (+3.333%)
Others

16/07/2019 14:10

Consun Pharma (01681) gets drug registration approvals

[ET Net News Agency, 16 July 2019] Consun Pharmaceutical Group Limited (01681) said the
respective drug registration approvals of the "Iopamidol Injection" of two specifications,
namely 100ml:30g(I) and 100ml:37g(I), developed by its subsidiary Guangzhou Consun
Pharmaceutical Company Limited, have been granted by the National Medical Products
Administration of the People's Republic of China.
The product is a contrast medium for computer tomography and is applicable to the
imaging of lesions in all body parts. As a non-ionic iodinated contrast medium, when
compared with other ionic iodinated contrast medium, it can improve the quality of
imaging, the scope of vascular imaging, the clearness of images from computer tomography
and the diagnostic accuracy of digital vascular subtraction. (RC)

Back to Others

Remark: Real time quote last updated: 19/04/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.